[1]
“ECG Changes in Patients of Visceral Leishmaniasis (Kala-Azar) Receiving Sodium Stibogluconate Therapy”, Faridpur Med Coll J, vol. 13, no. 2, pp. 70–73, Oct. 2019, doi: 10.3329/fmcj.v13i2.43624.